** Shares of medical device maker Zimmer Biomet ZBH.N fall 2.7% to $105
** Stock closed in red in six of seven past sessions
** Co expects 2025 adj. profit to be in range of $8.15 to $8.35 per share, below analysts' avg. est. of $8.56, anticipating hit from strong dollar - LSEG data
** Co's Q4 profit and revenue came in above expectations, driven by increased demand for its devices used in hip and knee procedures
** Up to last close, stock fell ~15% in last 12 months vs 4.3% rise in S&P 500 health care index .SPXHC
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.